• Tesamorelin 218949-48-5

  • Tesamorelin 218949-48-5

  • Tesamorelin 218949-48-5

Tesamorelin 218949-48-5

Tesamorelin (CAS No. 218949-48-5) is a synthetic peptide analogue of growth hormone-releasing hormone (GHRH), designed to stimulate the secretion of endogenous growth hormone. Tesamorelin has attracted significant attention in metabolic and endocrine research due to its ability to regulate fat metabolism, improve body composition, and enhance growth hormone-dependent pathways.

Product Description

Key Features & Advantages

 

Stimulates Endogenous Growth Hormone Release

 

Tesamorelin promotes the natural secretion of growth hormone (GH) from the pituitary gland, supporting studies on GH regulation, endocrine function, and hormone therapy development.

 

Reduces Visceral Fat and Supports Metabolic Health

 

Research demonstrates Tesamorelin's ability to reduce abdominal and visceral fat, making it valuable in preclinical studies on metabolic syndrome, lipodystrophy, and obesity-related research.

 

Enhances Protein Synthesis and Tissue Maintenance

 

By stimulating GH pathways, Tesamorelin supports protein metabolism, tissue growth, and regeneration, which is relevant for musculoskeletal research and regenerative medicine studies.

 

Supports Cardiovascular and Lipid Regulation

 

Tesamorelin's effects on metabolism also extend to lipid regulation and potential cardiovascular benefits, making it a candidate molecule for metabolic and cardiovascular research models.

 

Safe and Research-Grade

 

Tesamorelin is highly purified and non-toxic in research settings, suitable for in vitro and in vivo experimental studies and long-term investigations.

 

Molecular Details

 

Parameter Description
CAS Number 218949-48-5
Product Name Tesamorelin
Molecular Formula C₁₉₉H₃₀₉N₅₇O₆₂
Molecular Weight 4447.2 g/mol
Amino Acid Sequence Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Lys-Leu-Leu-Ser-Gln-Gln-Leu-Leu-Gln-Glu-Ser-Arg-Ile-Gln-Asn-OH
Appearance White to off-white lyophilized powder
Storage Store at –20°C, protected from light

 

Specifications & Packaging

 

Specification Option
Purity ≥98% (HPLC)
Form Lyophilized powder
Vial Sizes 2 mg, 5 mg, 10 mg, 50 mg (custom options available)
Packaging Sterile sealed vials; moisture-resistant, temperature-controlled packaging
Shelf Life 24 months under recommended storage conditions

 

Applications in Research and Development

 

1. Growth Hormone Regulation Studies

 

Tesamorelin is widely used in research to study GH secretion, pituitary function, and endocrine regulation mechanisms.

 

2. Metabolic Disorder Research

 

Tesamorelin's effects on visceral fat reduction and lipid metabolism make it an important molecule for studies on lipodystrophy, obesity, and metabolic syndrome.

 

3. Musculoskeletal & Tissue Growth Research

 

By stimulating GH-dependent pathways, Tesamorelin supports protein synthesis, tissue growth, and regenerative medicine studies.

 

4. Cardiovascular and Lipid Regulation Research

 

Tesamorelin's influence on lipid metabolism provides research opportunities for cardiovascular health, insulin resistance, and metabolic regulation studies.

 

5. Peptide-Based Therapeutic Development

 

Tesamorelin is a valuable compound in experimental drug development targeting growth hormone deficiencies, metabolic disorders, and body composition optimization.